Page 387 - medicina-integrativa_compress

388 PARTE II, SECCIÓN 6 TRASTORNOS METABÓLICOS Y ENDOCRINOS

Soldatos G: Advanced-glycation end products in insulin-resistant states. liver disease: A preliminary open pilot study. Minerva Gastroenterol
Curr Hypertens Rep 7:96-102, 2005. Dietol 51:193-199, 2005.
Song Y: Magnesium intake, C-reactive protein, and the prevalence of Troxel WM: Marital quality and occurrence of the metabolic syndrome in
metabolic syndrome in middle-aged and older U.S. women. women. Arch Intern Med 165:1022-1027, 2005.
Diabetes Care 28:1438-1444, 2005. Volek JS: Modification of lipoproteins by very low-carbohydrate diets.
Stern MP, Williams K, Haffner SM: Identification of persons at high risk J Nutr. 135:1339-1342, 2005.
for type 2 diabetes mellitus: Do we need the oral glucose tolerance Valachovicova M, Krajcovicova-Kudlackova M, Blazicek P, Babinska K:
test? Ann Intern Med 136:575-581, 2002. No evidence of insulin resistance in normal weight vegetarians:
Stocker CJ: Fetal origins of insulin resistance and obesity. Proc Nutr Soc A case control study. Eur J Nutr 45:52-54, 2005.
64:143-151, 2005. Vgontzas AN, Bixler EO, Chrousos GP: Sleep apnea is a manifestation of
Todaro JF: Combined effect of the metabolic syndrome and hostility on the metabolic syndrome. Sleep Med Rev 9:211-224, 2005.
the incidence of myocardial infarction (the normative aging study). Xu ME, Xiao SZ, Sun YH, et al: The study of anti-metabolic syndrome
Am J Cardiol 96:221-226, 2005. effect of puerarin in vitro. Life Sci 77:3183-3196, 2005.
Trappoliere M: Effects of a new pharmacological complex (sylibin + Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS: Systematic review of
vitamin E + phospholipids) on some markers of metabolic herbs and dietary supplements for glycemic control in diabetes.
syndrome and of a liver fibrosis in patients with non-alcoholic fatty Diabetes Care 26:1277-1294, 2003.